Article Details

Jounce Therapeutics Reports Results from Phase 2 Randomized SELECT Trial Testing 2 ...

Retrieved on: 2022-08-31 08:25:47

Tags for this article:

Click the tags to see associated articles and topics

Jounce Therapeutics Reports Results from Phase 2 Randomized SELECT Trial Testing 2 .... View article details on hiswai:

Excerpt

Vopratelimab is a clinical-stage monoclonal antibody that binds to and activates ICOS, the Inducible T cell CO-Stimulator, a protein on the surface of ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up